Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Current Leases (2019 - 2026)

Scynexis' (SCYX) quarterly Current Leases came in at $526000.0 in Q2 2026, up 18.47% on a YoY basis from $444000.0 in Q2 2025, and up 4.37% quarter-over-quarter from $504000.0 in Q1 2026.

Analysis

Scynexis (SCYX) Current Leases (2019 - 2026) Analysis & Trends

Scynexis (SCYX) has reported Current Leases for 8 consecutive years, with $526000.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Current Leases rose 18.47% year-over-year to $526000.0; the trailing twelve-month figure through Jun 2026 stood at $526000.0 (up 18.47% YoY), and the FY2025 full-year result was $483000.0, up 18.67% from the prior year.
  • Current Leases rose to $526000.0 in Q2 2026 per SCYX's latest filing, from $504000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $526000.0 in Q2 2026 and bottomed at $77000.0 in Q1 2022.
  • Historically, Current Leases has averaged $359277.8 across 5 years, with a median of $364000.0 in 2024.
  • The sharpest annual moves came in 2022 and 2026: Current Leases jumped 313.85% in 2022, then grew 18.47% in 2026.
  • Over 5 years, Current Leases stood at $282000.0 in 2022, then gained by 20.57% to $340000.0 in 2023, then advanced by 19.71% to $407000.0 in 2024, then gained by 18.67% to $483000.0 in 2025, then rose by 8.9% to $526000.0 in 2026.
  • According to Business Quant data, Current Leases over the past three periods registered $526000.0, $504000.0, and $483000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn -
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 720.00 Mn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 11.00 Mn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 45.93 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 12.38 Mn
10 Scynexis 58.41 Mn -56.29 Mn - 526,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 526,000.00
Mar 31, 2026 504,000.00
Dec 31, 2025 483,000.00
Sep 30, 2025 463,000.00
Jun 30, 2025 444,000.00
Mar 31, 2025 425,000.00
Dec 31, 2024 407,000.00
Sep 30, 2024 389,000.00
Jun 30, 2024 372,000.00
Mar 31, 2024 356,000.00
Dec 31, 2023 340,000.00
Sep 30, 2023 325,000.00
Jun 30, 2023 310,000.00
Mar 31, 2023 296,000.00
Dec 31, 2022 282,000.00
Sep 30, 2022 269,000.00
Jun 30, 2022 199,000.00
Mar 31, 2022 77,000.00
Dec 31, 2021 70,000.00
Sep 30, 2021 65,000.00